In Response to Gil Kerlikowske Response.
This patent was the outcome from research conducted by:
• Dr. Aiden J. Hampson, a neuropharmacologist at the National Institute for Mental Health (NIMH) in Bethesda, Maryland
• Dr. Julius Axelrod, Professor Emeritus, National Institutes of Health, pharmacologist and neuroscientist who shared the 1970 Nobel Prize in Physiology and Medicine
Cannabinoids are used to treat diseases including auto-immune disorders, stroke, trauma, Parkinson's, Alzeheimer's and HIV dementia.
The Patent is biased on research DONE by NIMH. Which has been stated in previous press releases as being able to treat said above diseases. We request that If it is made into federal law, those who have obtained a legal prescription, not be prosecuted.
This is historical material “frozen in time”. The website is no longer updated and links to external websites and some internal pages may not work.
